Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lactobacillus Fermentum
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Premier Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable
HEM1036 Phase 2 Study in Low Anterior Resection Syndrome
Details : Lactobacillus Fermentum is a Probiotic drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Low Anterior Resection Syndrome.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
September 02, 2022
Lead Product(s) : Lactobacillus Fermentum
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Premier Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable